"For me the main worry buying in now would be whether the company be around for 12 months to get CGT discount "
I'm sure you remarked this in jest, and I smiled just thinking about it. From my point of view I'd gladly accept a very large offer, even if it was taxable at the usual rates.
But getting back to your implied point, of a takeover within the next 12 months:
I did read somewhere (I don't recall whether it was just gossip on HC, or a more reliable source) that AT's position is that he acknowledges the likelihood of CU6 being taken out in due course. But if the trials progress with the same degree of positivity for prostrate cancer detection and therapy, and now with another $120 million +/- in the kitty, I'd be surprised if they didn't advance the R & D onto breast cancer as was initially planned in the Prospectus.
I'm sure there are many more informed commentators on this - anyone?
"For me the main worry buying in now would be whether the...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.65 |
Change
0.380(11.6%) |
Mkt cap ! $1.134B | |||
| Open | High | Low | Value | Volume |
| $3.30 | $3.75 | $3.29 | $15.67M | 4.533M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6405 | $3.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.65 | 13893 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.65 |
Change
0.380 ( 11.9 %) |
||||
| Open | High | Low | Volume | ||
| $3.29 | $3.76 | $3.29 | 345059 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| CU6 (ASX) Chart |